Selected research
Industry Growth & Trends
Global Preterm Birth Prevention and Management Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Preterm Birth Prevention and Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Preterm Birth Prevention and Management is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Preterm Birth Prevention and Management is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Preterm Birth Prevention and Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Preterm Birth Prevention and Management market include Teva, Sanofi, Novartis, Pfizer, Bayer, AbbVie, Viatris, Merck & Co and Ferring Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Preterm Birth Prevention and Management market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Preterm Birth Prevention and Management market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Preterm Birth Prevention and Management market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Preterm Birth Prevention and Management.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Preterm Birth Prevention and Management market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Preterm Birth Prevention and Management Market by Company
Teva
Sanofi
Novartis
Pfizer
Bayer
AbbVie
Viatris
Merck & Co
Ferring Pharmaceutical
Aurobindo Pharma
AMAG Pharmaceuticals
Allergan
Preterm Birth Prevention and Management Segment by Type
Antihypertensive Therapy
Magnesium Sulfate Therapy
Corticosteroid Therapy
Tocolytics Therapy
Progesterone Therapy
Other
Preterm Birth Prevention and Management Segment by Application
Hospital
Drugs Stores
Other
Preterm Birth Prevention and Management Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preterm Birth Prevention and Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Preterm Birth Prevention and Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preterm Birth Prevention and Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Preterm Birth Prevention and Management companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Antihypertensive Therapy
- Magnesium Sulfate Therapy
- Corticosteroid Therapy
- Tocolytics Therapy
- Progesterone Therapy
- Other
Applications
- Hospital
- Drugs Stores
- Other
Companies covered
- Teva
- Sanofi
- Novartis
- Pfizer
- Bayer
- AbbVie
- Viatris
- Merck & Co
- Ferring Pharmaceutical
- Aurobindo Pharma
- AMAG Pharmaceuticals
- Allergan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Preterm Birth Prevention and Management Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Preterm Birth Prevention and Management Market Size by Region (2021-2032)
- 1.4.1 Global Preterm Birth Prevention and Management Market Size by Region (2021-2026)
- 1.4.2 Global Preterm Birth Prevention and Management Market Size by Region (2027-2032)
- 1.5 Key Regions Preterm Birth Prevention and Management Market Size (2021-2032)
- 1.5.1 North America Preterm Birth Prevention and Management Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Preterm Birth Prevention and Management Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Preterm Birth Prevention and Management Market Size Growth Rate (2021-2032)
- 1.5.4 South America Preterm Birth Prevention and Management Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Preterm Birth Prevention and Management Market Size Growth Rate (2021-2032)
2 Preterm Birth Prevention and Management Market by Type
- 2.1 Type Introduction
- 2.1.1 Antihypertensive Therapy
- 2.1.2 Magnesium Sulfate Therapy
- 2.1.3 Corticosteroid Therapy
- 2.1.4 Tocolytics Therapy
- 2.1.5 Progesterone Therapy
- 2.1.6 Other
- 2.2 Global Preterm Birth Prevention and Management Market Size by Type
- 2.2.1 Global Preterm Birth Prevention and Management Market Size Overview by Type (2021-2032)
- 2.2.2 Global Preterm Birth Prevention and Management Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Preterm Birth Prevention and Management Market Size Forecasted by Type (2027-2032)
- 2.3 Global Preterm Birth Prevention and Management Market Size by Regions
- 2.3.1 North America Preterm Birth Prevention and Management Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Preterm Birth Prevention and Management Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Preterm Birth Prevention and Management Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Preterm Birth Prevention and Management Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Preterm Birth Prevention and Management Market Size Breakdown by Type (2021-2026)
3 Preterm Birth Prevention and Management Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Drugs Stores
- 3.1.3 Other
- 3.2 Global Preterm Birth Prevention and Management Market Size by Application
- 3.2.1 Global Preterm Birth Prevention and Management Market Size Overview by Application (2021-2032)
- 3.2.2 Global Preterm Birth Prevention and Management Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Preterm Birth Prevention and Management Market Size Forecasted by Application (2027-2032)
- 3.3 Global Preterm Birth Prevention and Management Market Size by Regions
- 3.3.1 North America Preterm Birth Prevention and Management Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Preterm Birth Prevention and Management Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Preterm Birth Prevention and Management Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Preterm Birth Prevention and Management Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Preterm Birth Prevention and Management Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Preterm Birth Prevention and Management Industry Trends
- 4.2 Preterm Birth Prevention and Management Industry Drivers
- 4.3 Preterm Birth Prevention and Management Industry Opportunities and Challenges
- 4.4 Preterm Birth Prevention and Management Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Preterm Birth Prevention and Management Revenue (2021-2026)
- 5.2 Global Preterm Birth Prevention and Management Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Preterm Birth Prevention and Management Key Company Headquarters & Area Served
- 5.4 Global Preterm Birth Prevention and Management Company, Product Type & Application
- 5.5 Global Preterm Birth Prevention and Management Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Preterm Birth Prevention and Management Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Preterm Birth Prevention and Management Players Market Share by Revenue in 2025
- 5.6.3 2025 Preterm Birth Prevention and Management Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Teva
- 6.1.1 Teva Company Information
- 6.1.2 Teva Business Overview
- 6.1.3 Teva Preterm Birth Prevention and Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Teva Preterm Birth Prevention and Management Product Portfolio
- 6.1.5 Teva Recent Developments
- 6.2 Sanofi
- 6.2.1 Sanofi Company Information
- 6.2.2 Sanofi Business Overview
- 6.2.3 Sanofi Preterm Birth Prevention and Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Sanofi Preterm Birth Prevention and Management Product Portfolio
- 6.2.5 Sanofi Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Preterm Birth Prevention and Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Novartis Preterm Birth Prevention and Management Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Pfizer
- 6.4.1 Pfizer Company Information
- 6.4.2 Pfizer Business Overview
- 6.4.3 Pfizer Preterm Birth Prevention and Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Pfizer Preterm Birth Prevention and Management Product Portfolio
- 6.4.5 Pfizer Recent Developments
- 6.5 Bayer
- 6.5.1 Bayer Company Information
- 6.5.2 Bayer Business Overview
- 6.5.3 Bayer Preterm Birth Prevention and Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Bayer Preterm Birth Prevention and Management Product Portfolio
- 6.5.5 Bayer Recent Developments
- 6.6 AbbVie
- 6.6.1 AbbVie Company Information
- 6.6.2 AbbVie Business Overview
- 6.6.3 AbbVie Preterm Birth Prevention and Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 AbbVie Preterm Birth Prevention and Management Product Portfolio
- 6.6.5 AbbVie Recent Developments
- 6.7 Viatris
- 6.7.1 Viatris Company Information
- 6.7.2 Viatris Business Overview
- 6.7.3 Viatris Preterm Birth Prevention and Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Viatris Preterm Birth Prevention and Management Product Portfolio
- 6.7.5 Viatris Recent Developments
- 6.8 Merck & Co
- 6.8.1 Merck & Co Company Information
- 6.8.2 Merck & Co Business Overview
- 6.8.3 Merck & Co Preterm Birth Prevention and Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Merck & Co Preterm Birth Prevention and Management Product Portfolio
- 6.8.5 Merck & Co Recent Developments
- 6.9 Ferring Pharmaceutical
- 6.9.1 Ferring Pharmaceutical Company Information
- 6.9.2 Ferring Pharmaceutical Business Overview
- 6.9.3 Ferring Pharmaceutical Preterm Birth Prevention and Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Ferring Pharmaceutical Preterm Birth Prevention and Management Product Portfolio
- 6.9.5 Ferring Pharmaceutical Recent Developments
- 6.10 Aurobindo Pharma
- 6.10.1 Aurobindo Pharma Company Information
- 6.10.2 Aurobindo Pharma Business Overview
- 6.10.3 Aurobindo Pharma Preterm Birth Prevention and Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Aurobindo Pharma Preterm Birth Prevention and Management Product Portfolio
- 6.10.5 Aurobindo Pharma Recent Developments
- 6.11 AMAG Pharmaceuticals
- 6.11.1 AMAG Pharmaceuticals Company Information
- 6.11.2 AMAG Pharmaceuticals Business Overview
- 6.11.3 AMAG Pharmaceuticals Preterm Birth Prevention and Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 AMAG Pharmaceuticals Preterm Birth Prevention and Management Product Portfolio
- 6.11.5 AMAG Pharmaceuticals Recent Developments
- 6.12 Allergan
- 6.12.1 Allergan Company Information
- 6.12.2 Allergan Business Overview
- 6.12.3 Allergan Preterm Birth Prevention and Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Allergan Preterm Birth Prevention and Management Product Portfolio
- 6.12.5 Allergan Recent Developments
7 North America
- 7.1 North America Preterm Birth Prevention and Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Preterm Birth Prevention and Management Market Size by Country (2021-2026)
- 7.3 North America Preterm Birth Prevention and Management Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Preterm Birth Prevention and Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Preterm Birth Prevention and Management Market Size by Country (2021-2026)
- 8.3 Europe Preterm Birth Prevention and Management Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Preterm Birth Prevention and Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Preterm Birth Prevention and Management Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Preterm Birth Prevention and Management Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Preterm Birth Prevention and Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Preterm Birth Prevention and Management Market Size by Country (2021-2026)
- 10.3 South America Preterm Birth Prevention and Management Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Preterm Birth Prevention and Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Preterm Birth Prevention and Management Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Preterm Birth Prevention and Management Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst